Authors:
Leblanc, Y
Dulk, GA
Vourlidas, A
Bougeret, JL
Citation: Y. Leblanc et al., Tracing shock waves from the corona to 1 AU: Type II radio emission and relationship with CMEs, J GEO R-S P, 106(A11), 2001, pp. 25301-25312
Authors:
Nicoll-Griffith, DA
Silva, JM
Chauret, N
Day, S
Leblanc, Y
Roy, P
Yergey, JA
Dixit, R
Patrick, D
Citation: Da. Nicoll-griffith et al., Application of rat hepatocyte culture to predict in vivo metabolic auto-induction: Studies with DFP, a cyclooxygenase-2 inhibitor, DRUG META D, 29(2), 2001, pp. 159-165
Authors:
Therien, M
Gauthier, JY
Leblanc, Y
Leger, S
Perrier, H
Prasit, P
Wang, ZI
Citation: M. Therien et al., Synthesis of rofecoxib, (MK 0966, Vioxx((R)) 4-(4 '-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone), a selective and orally active inhibitor of cyclooxygenase-2, SYNTHESIS-S, (12), 2001, pp. 1778-1779
Authors:
Leblanc, Y
Dulk, GA
Vourlidas, A
Bougeret, JL
Citation: Y. Leblanc et al., Flare- and coronal mass ejection (CME)-associated type II bursts and related radio emissions, J GEO R-S P, 105(A8), 2000, pp. 18225-18234
Authors:
Dulk, GA
Leblanc, Y
Bastian, TS
Bougeret, JL
Citation: Ga. Dulk et al., Acceleration of electrons at type II shock fronts and production of shock-accelerated type III bursts, J GEO R-S P, 105(A12), 2000, pp. 27343-27352
Authors:
Leblanc, Y
Roy, P
Boyce, S
Brideau, C
Chan, CC
Charleson, S
Gordon, R
Grimm, E
Guay, J
Leger, S
Li, CS
Riendeau, D
Visco, D
Wang, Z
Webb, J
Xu, LJ
Prasit, P
Citation: Y. Leblanc et al., Sar in the alkoxy lactone series: The discovery of DFP, a potent and orally active COX-2 inhibitor, BIOORG MED, 9(15), 1999, pp. 2207-2212
Authors:
Prasit, P
Wang, Z
Brideau, C
Chan, CC
Charleson, S
Cromlish, W
Ethier, D
Evans, JF
Ford-Hutchinson, AW
Gauthier, JY
Gordon, R
Guay, J
Gresser, M
Kargman, S
Kennedy, B
Leblanc, Y
Leger, S
Mancini, J
O'Neill, GP
Ouellet, M
Percival, MD
Perrier, H
Riendeau, D
Rodger, I
Tagari, P
Therien, M
Vickers, P
Wong, E
Xu, LJ
Young, RN
Zamboni, R
Boyce, S
Rupniak, N
Forrest, N
Visco, D
Patrick, D
Citation: P. Prasit et al., The discovery of rofecoxib, [MK 966, Vioxx (R), 4-(4 '-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitor, BIOORG MED, 9(13), 1999, pp. 1773-1778
Authors:
Chan, CC
Boyce, S
Brideau, C
Charleson, S
Cromlish, W
Ethier, D
Evans, J
Ford-Hutchinson, AW
Forrest, MJ
Gauthier, JY
Gordon, R
Gresser, M
Guay, J
Kargman, S
Kennedy, B
Leblanc, Y
Leger, S
Mancini, J
O'Neill, GP
Ouellet, M
Patrick, D
Percival, MD
Perrier, H
Prasit, P
Rodger, I
Tagari, P
Therien, M
Vickers, P
Visco, D
Wang, Z
Webb, J
Wong, E
Xu, LJ
Young, RN
Zamboni, R
Riendeau, D
Citation: Cc. Chan et al., Rofecoxib [Vioxx, MK-0966; 4-(4 '-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: A potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles, J PHARM EXP, 290(2), 1999, pp. 551-560
Authors:
Black, WC
Brideau, C
Chan, CC
Charleson, S
Chauret, N
Claveau, D
Ethier, D
Gordon, R
Greig, G
Guay, J
Hughes, G
Jolicoeur, P
Leblanc, Y
Nicoll-Griffith, D
Ouimet, N
Riendeau, D
Visco, D
Wang, ZY
Xu, L
Prasit, P
Citation: Wc. Black et al., 2,3-diarylcyclopentenones as orally active, highly selective cyclooxygenase-2 inhibitors, J MED CHEM, 42(7), 1999, pp. 1274-1281
Authors:
Dulk, GA
Leblanc, Y
Sault, RJ
Bolton, SJ
Waite, JH
Connerney, JEP
Citation: Ga. Dulk et al., Jupiter's magnetic field as revealed by the synchrotron radiation belts - I. Comparison of a 3-D reconstruction with models of the field, ASTRON ASTR, 347(3), 1999, pp. 1029-1038
Citation: Ga. Dulk et al., Jupiter's magnetic field as revealed by the synchrotron radiation belts - II. Change of the 2-D brightness distribution with D-E, ASTRON ASTR, 347(3), 1999, pp. 1039-1045